Michelle Xia on Akeso's Groundbreaking Progress with Cadonilimab | Michelle Xia, CEO, Akeso Inc. 00:10:00

Share On Facebook Share On Twitter

Michelle Xia, CEO of Akeso, a leading biopharmaceutical company, delves into the advancements in their innovative cancer treatment, Cadonilimab. In this discussion, she highlights the drug's development, its dual mechanism in immunotherapy, and its potential to revolutionize cancer care.

Recent Videos